IB
Healthcare & Life Sciences
Interdict Bio
United Stateswww.interdictbio.com/
Interdict Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Interdict Bio
Based in the United States, Interdict Bio is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Interdict Bio develops orally bioavailable small-molecule drugs called Interdictors™ that selectively inhibit protein synthesis by the ribosome in a context-dependent manner to target historically undruggable proteins involved in oncology, neurodegeneration, and rare diseases.
Explore Interdict Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.